(2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide

C55H70F3N9O5S — CID 167692182

IUPAC(2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide
SMILESCC(C)c1ncccc1-c1c2c3cc(ccc3n1CC(F)(F)F)-c1csc(n1)C[C@H](NC(=O)[C@H](C1CCCC1)N1CC[C@]3(CCN(C(=O)[C@H]4[C@@H](C5CC5)N4C)C3)C1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C55H70F3N9O5S/c1-32(2)44-36(12-8-20-59-44)47-38-26-53(3,4)31-72-52(71)39-13-9-21-67(62-39)50(69)40(25-43-60-41(27-73-43)35-16-17-42(37(38)24-35)66(47)30-55(56,57)58)61-49(68)46(33-10-6-7-11-33)64-22-18-54(28-64)19-23-65(29-54)51(70)48-45(63(48)5)34-14-15-34/h8,12,16-17,20,24,27,32-34,39-40,45-46,48,62H,6-7,9-11,13-15,18-19,21-23,25-26,28-31H2,1-5H3,(H,61,68)/t39-,40-,45+,46-,48+,54-,63?/m0/s1
InChIKeyXCOARIWXNBGVLG-WJBDFHQKSA-N
MW1026.28 g/mol
LogP7.74
Rot. Bonds9

About (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide

(2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide (PubChem CID 167692182) has the molecular formula C55H70F3N9O5S and a molecular weight of 1026.28 g/mol. Its IUPAC name is (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide.

Molecular Properties

Compound Name(2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide
PubChem CID167692182
Molecular FormulaC55H70F3N9O5S
Molecular Weight1026.28 g/mol
Exact Mass1025.52
IUPAC Name(2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide
SMILESCC(C)c1ncccc1-c1c2c3cc(ccc3n1CC(F)(F)F)-c1csc(n1)C[C@H](NC(=O)[C@H](C1CCCC1)N1CC[C@]3(CCN(C(=O)[C@H]4[C@@H](C5CC5)N4C)C3)C1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C55H70F3N9O5S/c1-32(2)44-36(12-8-20-59-44)47-38-26-53(3,4)31-72-52(71)39-13-9-21-67(62-39)50(69)40(25-43-60-41(27-73-43)35-16-17-42(37(38)24-35)66(47)30-55(56,57)58)61-49(68)46(33-10-6-7-11-33)64-22-18-54(28-64)19-23-65(29-54)51(70)48-45(63(48)5)34-14-15-34/h8,12,16-17,20,24,27,32-34,39-40,45-46,48,62H,6-7,9-11,13-15,18-19,21-23,25-26,28-31H2,1-5H3,(H,61,68)/t39-,40-,45+,46-,48+,54-,63?/m0/s1
InChIKeyXCOARIWXNBGVLG-WJBDFHQKSA-N
XLogP7.74
TPSA145.01 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms73
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001026.28
LogP ≤ 57.74
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide?
The IUPAC name of (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide (CID 167692182) is (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide.
What is the SMILES notation for (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide?
The canonical SMILES for (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide is CC(C)c1ncccc1-c1c2c3cc(ccc3n1CC(F)(F)F)-c1csc(n1)C[C@H](NC(=O)[C@H](C1CCCC1)N1CC[C@]3(CCN(C(=O)[C@H]4[C@@H](C5CC5)N4C)C3)C1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2.
What is the InChIKey of (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide?
The InChIKey is XCOARIWXNBGVLG-WJBDFHQKSA-N. The full InChI is InChI=1S/C55H70F3N9O5S/c1-32(2)44-36(12-8-20-59-44)47-38-26-53(3,4)31-72-52(71)39-13-9-21-67(62-39)50(69)40(25-43-60-41(27-73-43)35-16-17-42(37(38)24-35)66(47)30-55(56,57)58)61-49(68)46(33-10-6-7-11-33)64-22-18-54(28-64)19-23-65(29-54)51(70)48-45(63(48)5)34-14-15-34/h8,12,16-17,20,24,27,32-34,39-40,45-46,48,62H,6-7,9-11,13-15,18-19,21-23,25-26,28-31H2,1-5H3,(H,61,68)/t39-,40-,45+,46-,48+,54-,63?/m0/s1.
What are the key properties of (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide?
(2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide has a molecular weight of 1026.28 g/mol, XLogP of 7.74, 9 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(7S,13S)-17,17-dimethyl-8,14-dioxo-20-(2-propan-2-yl-3-pyridinyl)-21-(2,2,2-trifluoroethyl)-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]acetamide is sourced from PubChem (CID 167692182), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).